Sabon Nazari Yana Ƙimar Ƙarfin Masimo EMMA® Capnography don Tantance Matsayin Numfashi a cikin Yara Tracheostomy

Neuchatel, Swizalan -- (KASUWA WIRE) - Masimo (NASDAQ: MASI) a yau ya sanar da sakamakon binciken da aka yi a baya da aka buga a cikin International Journal of Pediatrics. A cikin wannan binciken, masu bincike a Asibitin Mata da Yara na Osaka a Japan sun gano cewa. Masimo EMMA® capnometer šaukuwa "ana iya amfani da shi don tantance yanayin numfashi na yara masu fama da tracheotomy." 1 EMMA® yana samuwa a cikin ƙaramin tsari don marasa lafiya na shekaru daban-daban. babu daidaitawa na yau da kullun, yana da ƙaramin lokacin dumi, kuma yana nuna daidaitaccen ma'aunin carbon dioxide na ƙarshe (EtCO2) da ma'aunin ƙimar numfashi gami da ci gaba da sigar EtCO2 a cikin daƙiƙa 15.
Yin la'akari da yuwuwar ƙimar ƙaƙƙarfan hanya da šaukuwa don lura da canje-canje a cikin yanayin numfashi na marasa lafiya a cikin yanayin da ba za a iya samun kayan aikin sa ido na asibiti na yau da kullun ba, Dokta Masashi Hotta da abokan aiki sun nemi tantance amfanin EMMA capnography a cikin yara ta hanyar kwatanta. bayanai daga darajar EtCO2 daga na'urar EMMA (wanda aka haɗe zuwa ƙarshen bututun tracheostomy) kuma an auna ma'aunin venous partial pressure na carbon dioxide (PvCO2) don tracheotomy. Yayin da jijiyoyin bugun jini na carbon dioxide (PaCO2) ana ɗaukar zinari. misali don tantance matsayin numfashi, masu binciken sun zaɓi PvCO2 saboda "ɗaukar samfurori na arterial ya fi haɗari fiye da ɗaukar samfurori na venous," lura da cewa binciken ya nuna cewa PaCO2 da PvCO2.2,3 Sun dauki jarirai 9 (tsakaici shekaru 8 watanni) kuma idan aka kwatanta da wani. jimlar nau'i-nau'i 43 na karatun EtCO2-PvCO2.
Masu binciken sun sami daidaituwa tsakanin karatun EtCO2 da PvCO2 na 0.87 (95% tazarar amincewa 0.7 - 0.93; p <0.001) .Binciken bayanan ya nuna cewa karatun EtCO2 ya kasance a matsakaicin 10.0 mmHg ƙasa da ƙimar PvCO2 daidai (95). % yarjejeniyar iyaka ya kasance 1.0 - 19.1 mmHg. Masu bincike sunyi tunanin cewa yanayin EtCO2 ya kasance ƙasa da PvCO2 za'a iya bayyana shi ta hanyar "haɗuwa da iskar gas kusa da bututun tracheostomy saboda kasancewar sararin samaniya na jiki da na jiki. Tun da kusan dukkanin marasa lafiya sunyi amfani da su. tubes ba tare da cuffs ba, wannan na iya faruwa Wasu leaks.Haka kuma, kusan kashi biyu bisa uku na marasa lafiya suna da [cutar huhu na yau da kullun ko dysplasia na bronchopulmonary], wanda suka nuna yana taimakawa ga CO2 yayin fitar numfashi idan aka kwatanta da matsa lamba na CO2. a cikin jini Hankali ya ragu.
Sun kuma gano cewa bambance-bambancen tsaka-tsaki a cikin karatun da aka tattara yayin da marasa lafiya ke karɓar iskar injiniyoyi sun fi girma (28 na 43 nau'i-nau'i na bayanai). (p=0.043)
"Muna nuna kyakkyawar dangantaka mai kyau tsakanin PvCO2 da EtCO2 da kuma bayyana amfani da amfani da wannan capnometer ga yara masu fama da tracheotomy," masu binciken sun kammala, "EMMA za a iya amfani da shi don tantance yanayin numfashi na yara da ke fama da tracheotomy. EMMA yana da amfani musamman a ciki. saitunan kula da gida da saitunan marasa lafiya na irin waɗannan yaran."Sun kuma lura, "Babban ƙarfin wannan binciken shine cewa mun yi amfani da capnometer mai ɗaukar hoto don tantance EtCO2."
Masimo (NASDAQ: MASI) wani kamfani ne na fasahar likitanci na duniya wanda ke haɓakawa da kera manyan fasahohin sa ido na masana'antu, gami da sabbin ma'auni, na'urori masu auna firikwensin, masu saka idanu masu haƙuri, da sarrafa kansa da hanyoyin haɗin kai.Manufarmu ita ce haɓaka haƙuri. Sakamakon da rage farashin kulawa. An gabatar da shi a cikin 1995, Masimo SET® Measure-through Motion and Low Perfusion ™ pulse oximeter ya tabbatar da aikinsa akan sauran fasahar oximeter na bugun jini a cikin fiye da 100 masu zaman kansu da kuma nazarin haƙiƙa.4 Masimo SET® ya kuma kasance wanda aka nuna don taimakawa likitocin su rage tsananin ciwon huhu a cikin jarirai waɗanda ba a kai ga haihuwa ba,5 inganta gwajin CCHD a cikin jarirai,6 da kuma rage saurin amsa ƙoƙarin ƙungiyar yayin amfani da Masimo Patient SafetyNet™ don ci gaba da sa ido a cikin ɗakin bayan tiyata.Kunnawa, Canja wurin ICU da farashi.7-10 kimanta cewa Masimo SET® za a yi amfani da shi fiye da marasa lafiya miliyan 200 a manyan asibitoci da sauran wuraren kiwon lafiya a duniya,11 bisa ga 2020-21 US News & World Report Best Hospitals Honor Roll,11 kuma yana daya daga cikin manyan asibitocin 10 na 9 main pulse oximeters.12 Masimo ya ci gaba da inganta SET®, kuma a cikin 2018 ya sanar da cewa RD SET® firikwensin na SpO2 daidai a karkashin yanayin motsi ya inganta sosai, yana ba da likitocin da ke da karfin gwiwa cewa A cikin 2005, Masimo ya gabatar da fasahar rainbow® Pulse CO-Oximetry, wanda ke ba da damar ci gaba da lura da abubuwan da ke cikin jini a baya kawai an auna su, gami da jimlar haemoglobin (SpHb®). ), abun ciki na oxygen (SpOC™), carboxyhemoglobin (SpCO®), Methemoglobin (SpMet®), Pleth Variability Index (PVi®), RPVi™ (rainbow® PVi) da Oxygen Reserve Index (ORi™) .A cikin 2013, Masimo ya ƙaddamar da shi. Tushen Kulawa da Kula da Haƙuri na Tushen® da Platform, wanda aka gina daga ƙasa har ya zama mai sassauƙa da haɓakawa kamar yadda zai yiwu don sauƙaƙe ƙari na sauran Masimo da fasahar saka idanu na ɓangare na uku;mahimmin ƙari ga Masimo sun haɗa da na gaba-tsara SedLine® Brain aikin saka idanu, O3® yanki na oxygen jikewa da ISA ™ capnography tare da NomoLine® samfurin line.Masimo's ci gaba da duba-duba saka idanu, Pulse CO-Oximeters®, ya hada da na'urorin da aka tsara don ana amfani da su a cikin yanayi iri-iri na asibiti da marasa lafiya, gami da fasahar sawa mara igiyar waya kamar Radius-7® da Radius PPG™, na'urori masu ɗaukar nauyi kamar Rad-67™, Fingertip pulse oximeters kamar MightySat® Rx da na'urori waɗanda zasu iya zama. Ana amfani da shi a asibiti da kuma gida kamar Rad-97®.Masimo aikin sarrafa kansa da hanyoyin haɗin kai sun dogara ne akan dandalin Masimo Hospital Automation™ kuma sun haɗa da Iris® Gateway, iSirona™, SafetyNet Patient, Replica™, Halo ION™, UniView ™, UniView:60™ da Masimo SafetyNet™.Don ƙarin bayani game da Masimo da samfuransa, ziyarci www.masimo.com. Ana iya samun karatun likitancin da aka buga akan samfuran Masimo a www.masimo.com/evidence/featured-studies/feature /.
ORI da RPVi ba su sami izini na FDA 510(k) ba kuma ba za a iya tallata su a cikin Amurka ba. Ana amfani da alamar kasuwancin Patient SafetyNet ƙarƙashin lasisi daga Ƙungiyar Jami'ar HealthSystem Consortium.
Wannan sakin latsa ya haɗa da maganganun sa ido a cikin ma'anar Sashe na 27A na Dokar Tsaro na 1933 da Sashe na 21E na Dokar Musanya Securities na 1934 dangane da Dokar Gyara Shari'ar Masu Zaman Kansu na 1995. Waɗannan maganganun na gaba sun haɗa da: Sauran , Bayani game da yuwuwar tasiri na EMMA®.Waɗannan maganganun na gaba sun dogara ne akan tsammanin abubuwan da ke faruwa a nan gaba da suka shafi mu kuma suna fuskantar haɗari da rashin tabbas, dukansu suna da wuyar tsinkaya, yawancin su sun fi ƙarfin mu kuma zasu iya. haifar da ainihin sakamakonmu ya bambanta da waɗanda saboda haɗari daban-daban Abubuwan da ke haifar da haɗarin da muke bayyanawa a cikin maganganunmu na gaba sun haɗa da, amma ba'a iyakance ga: hadarin da ke da alaka da tunaninmu game da sake haifar da sakamakon asibiti;dangane da imaninmu cewa fasahohin ma'aunin ma'auni na musamman na Masimo, gami da EMMA, suna ba da gudummawa ga ingantattun haɗarin asibiti masu alaƙa da sakamako da amincin haƙuri;Hadarin da ke da alaƙa da imaninmu cewa ci gaban likitancin da ba na Masimo ba ya ba da mafita mai tsada da fa'idodi na musamman;kasadar da ke da alaƙa da COVID-19;da takardun mu tare da Securities and Exchange Commission ("SEC") Ƙarin abubuwan da aka tattauna a cikin sashin "Haɗari" na sabon rahoton ana samun su kyauta akan gidan yanar gizon SEC a www.sec.gov.Ko da yake mun yi imani cewa abubuwan da ake tsammani A cikin maganganunmu masu hangen nesa suna da ma'ana, ba mu sani ba ko tsammaninmu zai tabbata daidai. sanya dogaro mara kyau ga waɗannan maganganun sa ido, waɗanda ke magana kawai a yau. Ba mu ɗauki alhakin sabunta, sake dubawa ko fayyace waɗannan maganganun ko "Abubuwan Haɗari" da ke ƙunshe a cikin rahotonmu na baya-bayan nan ga SEC, ko a sakamakon sabon bayani. , abubuwan da zasu faru nan gaba ko akasin haka, sai dai kamar yadda ake buƙata a ƙarƙashin dokokin tsaro masu aiki.
Wani sabon binciken ya gano cewa ana iya amfani da Masimo EMMA® Capnograph don tantance numfashi a cikin yara masu ciwon tracheostomy.